Join our smart investors - Get the best stock directories in  blockchain, cannabis, crypto, AI, IoT, cleantech. Daily podcasts in cannabis and crpto. Just $99  a year

Investor Ideas Potcasts #Cannabis News and Stocks on the Move: (TSXV: $NRTH.V) (TSX: $WEED.TO) (NYSE: $CGC) (TSXV: $META.V) (NYSE: $ACB) (TSX: $ACB.TO) (TSXV: $KHRN.V) (TSXV: $N.V)

This month’s cannabis podcasts brought to you by CLS Holdings USA, Inc. (OTCQB: $CLSH) @CLSHusa

 

Delta, Kelowna, BC - December 3, 2018 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca and its exclusive content partner, CLS Holdings USA, Inc. (OTCQB: CLSH), release today's edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.

CLS Holdings USA, Inc. (OTCQB: CLSH) is a diversified cannabis company operating as Cannabis Life Sciences an integrated cannabis producer and retailer in Nevada through its Oasis Cannabis subsidiaries with plans to expand into other States.

https://www.investorideas.com/Audio/Podcasts/2018/120318-StocksToWatch.mp3

Investor Ideas Potcasts #Cannabis News and Stocks on the Move: (TSXV: $NRTH.V) (TSX: $WEED.TO) (NYSE: $CGC) (TSXV: $META.V) (NYSE: $ACB) (TSX: $ACB.TO) (TSXV: $KHRN.V) (TSXV: $N.V)

Hear Investor ideas cannabis potcast on iTunes

Today's podcast overview/transcript:

Good afternoon, welcome to another Investorideas.com "potcast", featuring stocks to watch, cannabis news as well as insights from thought leaders and experts.

Today we will be looking at announcements from 48North Cannabis Corp. (TSXV:NRTH), Canopy Growth Corporation (TSX:WEED) (NYSE: CGC), National Access Cannabis Corp. (TSXV: META), Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB), Khiron Life Sciences Corp. (TSXV: KHRN), (OTCQB: KHRNF) and Namaste Technologies Inc. (TSXV: N) (OTCMKTS: NXTTF).

48North Cannabis Corp.announced today that it has entered into two agreements with Canopy Growth Corporation, a strategic investment financing and partnership and supply agreement.

Under the Supply Agreement, 48North will supply Canopy Growth with dried cannabis produced from high-grade, unique genetics, grown at 48North's wholly-owned facility, DelShen Therapeutics Corp. The total volume of the Supply Agreement is estimated to be a minimum of 1,200 kilograms and deliverable over the course of 12 months. The first 100-kilogram transfer under the Supply Agreement is expected to ship from 48North's DelShen facility to Canopy Growth by December 5, 2018.

Under the Financing Agreement, Canopy will invest $3 million into 48North and receive 4,000,000 Common Units at $0.75 per Unit. 48North will issue each Unit at $0.75 to Canopy Growth for $3 million, representing approximately 3.4% of the issued and outstanding shares. Each Unit will be comprised of one Common Share and one quarter Common Share Purchase Warrant.

The Supply Agreement further states that Canopy Growth will work with 48North on a non-binding but best-effort basis to establish a national retail presence for its products in Tokyo Smoke and Tweed stores.

National Access Cannabis Corp. (TSXV: META), a best practices leader in delivering secure, safe, and responsible access to legal cannabis in Canada, today announced that it had acquired all of NAC Alberta Inc.'s minority interest in NAC Northern Alberta GP and NAC Northern Alberta Limited Partnership for the forgiveness of $192,702 of debt and the issuance of 2,173,913 common shares of NAC at a price of $0.69 per NAC common share.

"This Acquisition gives NAC 100% ownership of all cannabis locations in Northern Alberta, other than Second Cup locations, at an attractive valuation, and streamlines the Company's Alberta strategy in a highly prospective area of the province," said Mark Goliger, CEO of NAC. "We plan on having approximately 8 non-Second Cup locations in 2018-2019 in Northern Alberta and see the potential for a sizable footprint in Northern Alberta as we grow to over an estimated 200 retail cannabis locations across the country."

As part of an anticipated opening of up to 200 retail cannabis locations across Canada, the Company continues to develop its retail strategy in Alberta, targeting opening a total of 37 cannabis retail stores by the end of 2019.

Aurora Cannabis Inc. announced today that, further to its October 17, 2018 announcement that it had received a sales license from Health Canada permitting the sale of cannabis softgel capsules, the Company has commenced shipments for both the Canadian medical and adult-use markets. Aurora expects to commence exports to international markets in early 2019.

At scale, the Company anticipates that softgel production at its state-of-the-art Aurora Vie facility in Quebec will reach at least 1.4 million capsules per week. Aurora intends to make this high-volume, high-margin, smoke-free, product available to all of its domestic and international target markets over time where legally possible.

Aurora's softgel capsules are produced to pharmaceutical-grade standards at Aurora Vie, in collaboration with leading softgel manufacturer Capcium Inc. ("Capcium"), in which Aurora holds a 19.99% ownership interest. The Company will initially launch the capsules to the medical cannabis market in Canada as well as the adult-use market in British Columbia with additional provincial markets to follow.

The Company is initially launching four softgel product types, each available in bottles of 30 capsules, priced at $45 per bottle. The small, easy to digest soft gelatin capsules are colour-coded to distinguish between the different varieties for the protection of public health and safety. They are believed to the smallest cannabis capsules on the market. Aurora's softgels provide a dosage-controlled format that medical practitioners and consumers around the world need to facilitate more precise administration.

Khiron Life Sciences Corp., an integrated medical cannabis company with its core operations in Colombia, announced today that its wholly-owned subsidiary, Kuida Life Mexico S.A., has received approval from Mexico's Federal Commission for the Protection against Sanitary Risk (COFEPRIS) to import and commercialize three products of the Company's Nutraceutical Line. The commencement of sales in Mexico is subject to prior TSX Venture Exchange approval.

The three initial products approved by COFEPRIS include; a CBD (cannabidiol) based formulation designed to help promote sleep; a CBD based food supplement designed as a digestive aide; and a CBD based supplement that is formulated to help promote the body's recovery following periods of exertion and stress. These products are developed under Khiron's wellness business unit, which is focused on offering the full benefits of cannabis for consumers across Latin America.

With these approvals, Khiron is positioned to market these products across Mexico, a country of over 120 million people, and with the largest per capita consumption of dietary supplements in Latin America, according to Euromonitor International. At the end of 2016 the market value of this sector in Mexico alone was US $552.1 Million and growing at an annual rate of 13.4% since 2011 (Euromonitor).

Alvaro Torres, Co-founder and CEO for Khiron stated, "Mexico is a priority market for Khiron, and through a previously announced distribution deal with Farmalisto, the region's leading digital drugstore, we are positioned to leverage their e-commerce capabilities to bring our products to customers across the region."

Namaste Technologies Inc. announced record-breaking unaudited gross revenue of more than $2.6 Million across its global online platform, representing approximately 52% growth from October 2018 and approximately 30% growth year-on-year after excluding US revenue derived during the month of November 2017. After a successful Black Friday through Cyber Monday holiday weekend and with strong sales through November, the Company anticipates seeing strong revenue in December and into the new year.

November revenue derived through Namaste's global platform was almost entirely from the sale of vaporizers and smoking accessories. The Company has been focused on cannabis sales through its wholly-owned subsidiary, Cannmart Inc., Canada's first medical cannabis sales-only licensed issued to a non-cultivator and an online marketplace where medical patients can purchase medical cannabis sourced from a variety of producers across Canada. By expanding on the product offering through Cannmart, the Company anticipates building its platform to represent the most diverse offering of high-quality cannabis products available in the Canadian market.

Cannmart recently announced the launch of same-day delivery within the Greater Toronto Area through its partners at Pineapple Express Delivery Inc. which has been well received by its patients. Cannmart also launched pre-rolled cannabis products in its platform and will be adding cannabis oils to its platform in the near future. Following Cannmart's recent acquisition of Buds2go.ca, it anticipates launching its second online platform through Buds2go this week. The acquisition of Buds2go.ca is significant the domain holds strong organic search rankings with more traffic than Cannmart. The Company recently announced its strategy to secure supply channels through future micro-cultivators, subject to the regulations Cannabis Act, and intends to offer the largest variety of craft cannabis products through Buds2go.ca.

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment

This podcast is sponsored by

CLS Holdings USA, Inc. (OTCQB: CLSH)

CLS Holdings USA, Inc. (CLSH) is a diversified cannabis company that, subject to receipt of certain anticipated regulatory approvals, acts as an integrated cannabis producer and retailer through its Oasis Cannabis subsidiaries in Nevada, and plans to expand to other states.

CLS stands for "Cannabis Life Sciences," in recognition of the Company's patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. The Company's business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services.

For additional information, please visit: http://www.clsholdingsinc.com

Twitter: @CLSHusa


Sign up to get the news alerts including the daily podcast and transcript for Investor ideas podcasts

Subscribe to the new cannabis podcast series:

https://www.investorideas.com/rss/feeds/Podcasts-Cannabis.xml

Or visit https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708


Get the cannabis/hemp stock directory as an Investor ideas member, plus get weekly updates with new pot stocks added and get the daily potcast for Investor Ideas #Potcasts #Cannabis News and Stocks on the Move. Learn more https://www.investorideas.com/membership/


About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers.

Disclosure this podcast is in partnership with featured sponsor CLS Holdings USA, Inc. (OTCQB: CLSH) details :

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp. Learn more about Investor ideas podcast and news publication services and costs https://www.investorideas.com/News-Upload/

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

Follow us on Social Media

https://www.facebook.com/Investorideaspotcasts/

https://twitter.com/MJInvestorIdeas

https://www.instagram.com/potcasts_investorideas/

Contact Investorideas.com

800-665-0411